Legis Daily

Essential Medicines Strategic Stockpile Act of 2021

USA117th CongressHR-2870| House 
| Updated: 4/29/2021
Earl L. "Buddy" Carter

Earl L. "Buddy" Carter

Republican Representative

Georgia

Cosponsors (1)
Lisa Blunt Rochester (Democratic)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Essential Medicines Strategic Stockpile Act of 2021 This bill requires the Department of Health and Human Services (HHS) to create a pilot program with private entities to test the effectiveness of acquiring, maintaining, managing, and distributing a stockpile of generic drugs at risk of shortage. Specifically, HHS must enter into contracts of up to three years for entities to create a six-month stockpile of up to 50 types of such drugs. The bill establishes various program requirements, including annual evaluations by the Government Accountability Office.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-8479
Essential Medicines Strategic Stockpile Act of 2020
Apr 28, 2021
Introduced in House
Apr 28, 2021
Referred to the House Committee on Energy and Commerce.
Apr 29, 2021
Referred to the Subcommittee on Health.
  • Bill from Previous Congress

    HR 116-8479
    Essential Medicines Strategic Stockpile Act of 2020


  • April 28, 2021
    Introduced in House


  • April 28, 2021
    Referred to the House Committee on Energy and Commerce.


  • April 29, 2021
    Referred to the Subcommittee on Health.

Health

Business recordsCongressional oversightEmergency medical services and trauma careGovernment information and archivesGovernment studies and investigationsHealth care coverage and accessHealth programs administration and fundingHealth technology, devices, suppliesPrescription drugsPublic contracts and procurementPublic-private cooperationStrategic materials and reserves

Essential Medicines Strategic Stockpile Act of 2021

USA117th CongressHR-2870| House 
| Updated: 4/29/2021
Essential Medicines Strategic Stockpile Act of 2021 This bill requires the Department of Health and Human Services (HHS) to create a pilot program with private entities to test the effectiveness of acquiring, maintaining, managing, and distributing a stockpile of generic drugs at risk of shortage. Specifically, HHS must enter into contracts of up to three years for entities to create a six-month stockpile of up to 50 types of such drugs. The bill establishes various program requirements, including annual evaluations by the Government Accountability Office.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-8479
Essential Medicines Strategic Stockpile Act of 2020
Apr 28, 2021
Introduced in House
Apr 28, 2021
Referred to the House Committee on Energy and Commerce.
Apr 29, 2021
Referred to the Subcommittee on Health.
  • Bill from Previous Congress

    HR 116-8479
    Essential Medicines Strategic Stockpile Act of 2020


  • April 28, 2021
    Introduced in House


  • April 28, 2021
    Referred to the House Committee on Energy and Commerce.


  • April 29, 2021
    Referred to the Subcommittee on Health.
Earl L. "Buddy" Carter

Earl L. "Buddy" Carter

Republican Representative

Georgia

Cosponsors (1)
Lisa Blunt Rochester (Democratic)

Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Business recordsCongressional oversightEmergency medical services and trauma careGovernment information and archivesGovernment studies and investigationsHealth care coverage and accessHealth programs administration and fundingHealth technology, devices, suppliesPrescription drugsPublic contracts and procurementPublic-private cooperationStrategic materials and reserves